GC38469
CBP/p300-IN-3
Also known as 2-[6-(diethylamino)-3-pyridinyl]-1-[(1-ethylpyrazol-3-yl)methyl]-N-methylbenzimidazole-5-carboxamide
CBP/p300-IN-3, a p300/CBP histone acetyltransferase inhibitor, Compound 6, is sourced from patent WO 2019049061 A1
ChemicalCAS2299226-01-8MW431.53FormulaC24H29N7O
- CAS number
- 2299226-01-8
- Molecular weight
- 431.53
- Formula
- C24H29N7O
- Solubility
- DMSO： 250 mg/mL (579·33 mM)
- InChIKey
- LYVJDLHFTGYNAV-UHFFFAOYSA-N
- Catalogue number
- GC38469
- Brand
- GLPBIO
Computed properties PubChem CID 138466007 · XLogP 2.7 · TPSA 80.9 Ų · H-bond donors 1
- XLogP
- 2.7
- TPSA
- 80.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 8
- Heavy atoms
- 32
SMILES CCN1C=CC(=N1)CN2C3=C(C=C(C=C3)C(=O)NC)N=C2C4=CN=C(C=C4)N(CC)CC
Computed descriptors from PubChem (CID 138466007), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il